Genprex, Inc. Quarterly Operating Income (Loss) in USD from Q3 2016 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Genprex, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2016 to Q3 2024.
Genprex, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.32M, a 44.5% increase year-over-year.
Genprex, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$22.8M, a 27.9% increase year-over-year.
Genprex, Inc. annual Operating Income (Loss) for 2023 was -$31.1M, a 30.4% decline from 2022.
Genprex, Inc. annual Operating Income (Loss) for 2022 was -$23.8M, a 15.3% decline from 2021.
Genprex, Inc. annual Operating Income (Loss) for 2021 was -$20.7M, a 15.1% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$22.8M	-$4.32M	+$3.46M	+44.5%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-13
Q2 2024	-$26.3M	-$6.52M	+$1.52M	+18.9%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-09
Q1 2024	-$27.8M	-$6M	+$3.27M	+35.3%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	-$31.1M	-$5.99M	+$592K	+9.01%	Oct 1, 2023	Dec 31, 2023	10-K	2024-04-01
Q3 2023	-$31.7M	-$7.79M	-$1.62M	-26.2%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-13
Q2 2023	-$30.1M	-$8.04M	-$2.27M	-39.3%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-09
Q1 2023	-$27.8M	-$9.26M	-$3.95M	-74.5%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-15
Q4 2022	-$23.8M	-$6.58M	+$1.35M	+17.1%	Oct 1, 2022	Dec 31, 2022	10-K	2024-04-01
Q3 2022	-$25.2M	-$6.17M	-$2.73M	-79.4%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-14
Q2 2022	-$22.5M	-$5.77M	-$1.78M	-44.7%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-21
Q1 2022	-$20.7M	-$5.31M	$0	0%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-22
Q4 2021	-$20.7M	-$7.93M	-$2.7M	-51.7%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-31
Q3 2021	-$18M	-$3.44M	-$661K	-23.8%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$17.3M	-$3.99M	+$391K	+8.93%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-12
Q1 2021	-$17.7M	-$5.31M	+$266K	+4.76%	Jan 1, 2021	Mar 31, 2021	10-K	2023-03-31
Q4 2020	-$18M	-$5.23M	-$2.8M	-115%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-30
Q3 2020	-$15.2M	-$2.78M	-$397K	-16.7%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-15
Q2 2020	-$14.8M	-$4.38M	-$674K	-18.2%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-13
Q1 2020	-$14.1M	-$5.58M	-$3.41M	-157%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-17
Q4 2019	-$10.7M	-$2.43M	+$1.02M	+29.5%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-26
Q3 2019	-$11.7M	-$2.38M	-$183K	-8.35%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-12
Q2 2019	-$11.5M	-$3.7M	+$2.33M	+38.6%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-11
Q1 2019	-$13.8M	-$2.17M	-$1.48M	-216%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-14
Q4 2018	-$12.4M	-$3.44M	-$2.78M	-418%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-30
Q3 2018	-$9.58M	-$2.2M	-$1.48M	-207%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-14
Q2 2018	-$8.1M	-$6.04M	-$4.85M	-411%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-13
Q1 2018	-$3.25M	-$687K	+$64.7K	+8.61%	Jan 1, 2018	Mar 31, 2018	10-Q/A	2019-05-20
Q4 2017	-$3.31M	-$665K			Oct 1, 2017	Dec 31, 2017	10-K	2019-04-01
Q3 2017		-$715K	+$4.74K	+0.66%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-14
Q2 2017		-$1.18M			Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-14
Q1 2017		-$751K			Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-15
Q3 2016		-$720K			Jul 1, 2016	Sep 30, 2016	10-Q/A	2017-12-05

* An asterisk sign (*) next to the value indicates that the value is likely invalid.